Ivey Business School (Canada)
-
Hewlett Packard eHealth Center: Healthcare Access Through Technology Convergence
Kajari Mukherjee; Michael J. Rouse; Bhuvaneashwar SubramanianCase IVEY-9B17M101-EStrategyIn 2012, eHealth Centers (eHCs) digitally delivered affordable medical care and diagnostic support for patients in villages and remote areas of India where it was otherwise unavailable. The solution was initially conceived and developed as a mandate from Hewlett Packard India’s corporate social responsibility team under the leadership of the chief technology officer. The eHCs design incorporated a self-contained diagnostic centre in a container, ...Starting at €8.20
-
Royal Dutch/Shell in Nigeria Stakeholder Simulation: Pengassan
Oana Branzei; David WheelerCase IVEY-9B08M075D-EStrategyThe goal of the Royal Dutch/Shell in Nigeria Stakeholder Simulation is to illustrate the challenges in anticipating points of common interest, and the difficulties of overcoming initial antagonistic conditions in order to work together to develop better positions. The simulation illustrates the tensions, trade-offs, and challenges involved in mapping and addressing competing stakeholder demands in a long-standing conflict where players' positions...Starting at €8.20
-
Change at Pfizer: Jeff Kindler (C) Post Wyeth Acquisition Organization
Michael J. Rouse; Chander SehgalCase IVEY-9B10M054-EStrategyThis case is a supplement to Change at Pfizer: Jeff Kindler (A).Starting at €5.74
-
GSK’s Andrew Witty: Addressing Neglected Tropical Diseases and Global Health Issues — Open Labs, Open Minds (B)
Michael J. Rouse; Chander SehgalCase IVEY-9B10M110-EStrategyThis case is a supplement to GSK’s Andrew Witty (A).Starting at €5.74
-
CSTAR
James E. Hatch; John S. Haywood-Farmer; Michael J. Rouse; Virginia Ritchie; Lyndsay Passmore; Leah HillierCase IVEY-9B09M017-EEntrepreneurship, StrategyCanadian Surgical Technologies and Advanced Robotics Centre (CSTAR) had had a successful year during which its new director had ensured that CSTAR's budget deficit was on target to be reduced by 50 per cent. CSTAR still faced significant hurdles to becoming financially stable and a leader in minimally invasive surgery (MIS). The director wanted CSTAR to be financially self-sustainable within two years, and identified goals to overcome these hurdl...Starting at €8.20
-
Guelph General Hospital
Michael J. Rouse; Justin Cottrell; Abhinay Sathya; Austin Allison; Daniel Korsunsky; Scott Anders McGillis; Moneca NicolsCase IVEY-9B16M038-EStrategyIn November 2010, the senior director of Inpatient Services at Guelph General Hospital, which was situated in a small city in Southwestern Ontario, Canada, was facing questions about the implementation of the Process Improvement Program, part of a province-wide pilot project. Beginning in October 2009, the program had been tested at the hospital to deal with a deteriorating organizational culture and poor performance reviews. Guelph General Hospi...Starting at €8.20
-
CAA Saskatchewan: Future of Auto Club
Bruce C. Anderson; Michael J. RouseCase IVEY-9B11M110-EEntrepreneurship, StrategyThe president and CEO of a provincial auto club is assessing opportunities to grow his organization at the same time as industry consolidation and changes in the allocation of national operating costs. The auto club has diversified from automobile towing and travel services into insurance, package travel, automobile sales, and service. However, the president's vision for the upcoming board of directors' meeting calls for a 300 per cent increase i...Starting at €8.20
-
GSK’s Andrew Witty: Addressing Neglected Tropical Diseases and Global Health Issues — The Pharmaceutical Patent Pool (A)
Michael J. Rouse; Chander SehgalCase IVEY-9B10M109-EStrategyIn February 2009, Andrew Witty, CEO of GlaxoSmithKline (GSK), reflected on his vision for big pharma as a catalyst for change which focussed on two key issues: 1) promoting innovation for the products that treat or prevent neglected tropical diseases and 2) improving access to medicines in the world’s poorest countries. He had announced the creation of the Pharmaceutical Patent Pool and wondered if it was the right strategy to deliver results on ...Starting at €8.20
-
Royal Dutch/Shell in Nigeria Stakeholder Simulation: The Movement for the Survival of the Ogoni People (MOSOP)
Oana Branzei; David WheelerCase IVEY-9B08M075B-EStrategyThe goal of the Royal Dutch/Shell in Nigeria Stakeholder Simulation is to illustrate the challenges in anticipating points of common interest, and the difficulties of overcoming initial antagonistic conditions in order to work together to develop better positions. The simulation illustrates the tensions, trade-offs, and challenges involved in mapping and addressing competing stakeholder demands in a long-standing conflict where players' positions...Starting at €8.20
-
Royal Dutch/Shell in Nigeria Stakeholder Simulation: Nigerian National Petroleum Corporation
Oana Branzei; David WheelerCase IVEY-9B08M075C-EStrategyThe goal of the Royal Dutch/Shell in Nigeria Stakeholder Simulation is to illustrate the challenges in anticipating points of common interest, and the difficulties of overcoming initial antagonistic conditions in order to work together to develop better positions. The simulation illustrates the tensions, trade-offs, and challenges involved in mapping and addressing competing stakeholder demands in a long-standing conflict where players’ positions...Starting at €8.20